Janssen Pharmaceuticals, INC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$124Mgeneral payments (2019-2025)
$1.00research payments (2019-2025)
217,564clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Spravato $16M associated (2023-2025)
- Invega Sustenna $12M associated (2023-2025)
- Xarelto $11M associated (2023-2025)
- Invega Trinza $9.3M associated (2023-2025)
- Invega $225K associated (2023-2025)
- Erleada $150K associated (2023-2025)
- Darzalex $149K associated (2023-2025)
- Talvey $90K associated (2023-2025)
- Rybrevant $90K associated (2023-2025)
- Tremfya $77K associated (2023-2025)
- Symtuza $51K associated (2023-2025)
- Ponvory $27K associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Henry Nasrallah | Cincinnati, OH | Psychiatry | $693,718.65 |
| Sanford Herman | Jamaica, NY | Psychiatry | $686,355.18 |
| Jay Fawver | Angola, IN | Psychiatry | $659,406.49 |
| Mark Reynolds | Durham, NC | Psychiatry | $601,243.08 |
| Matthew Becker | Erie, PA | Interventional Cardiology | $587,156.04 |
| Jason Kellogg | Irvine, CA | Psychiatry | $582,794.52 |
| Arthur Lee | Gainesville, FL | Interventional Cardiology | $547,586.27 |
| James Barker | Hickory, NC | Psychiatry | $531,620.48 |
| Lisa Harding | Milford, CT | Psychiatry | $528,874.29 |
| Vamsi Krishna | Kyle, TX | Interventional Cardiology | $518,297.22 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.